EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes

Stephanie Trejo Corona, Cecilia Villanueva Boone, Amna M Ali, Chelsey Moore, Alexandra Brown, Jose Munoz, Thomas Aaberg, Amy C Schefler, ARRT Study Group

Investigative Opthalmology & Visual Science · 23.06.2023 · 64 (7) · 35

DOI: 10.1167/iovs.64.7.35 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Investigative Opthalmology & Visual Science, erschienen am 23.06.2023. Verfasst von Stephanie Trejo Corona und 8 weiteren Autor:innen. Beteiligte Einrichtung: Retina Consultants of Texas, Retina Consultants of America, Houston, Texas, United States. Hauptthemen laut MEDLINE: Ranibizumab, Macular Edema. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RanibizumabMacular EdemaHumansAngiogenesis InhibitorsProspective StudiesReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsIntravitreal InjectionsTreatment Outcome

Substanzen

RanibizumabafliberceptAngiogenesis InhibitorsReceptors, Vascular Endothelial Growth FactorRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Retina Consultants of Texas, Retina Consultants of America, Houston, Texas, United States.
  • John P. and Kathrine G. McGovern Medical School at UT Health Houston, Houston, Texas, United States.
  • Retina Specialists of Michigan, Grand Rapids, Michigan, United States.
  • Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas, United States.

Zitieren

APA

Trejo Corona, S., Villanueva Boone, C., Ali, A. M., Moore, C., Brown, A., Munoz, J., Aaberg, T., Schefler, A. C., & ARRT Study Group (2023). Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes. Investigative Opthalmology & Visual Science, 64(7), 35. https://doi.org/10.1167/iovs.64.7.35

Vancouver

Trejo Corona S, Villanueva Boone C, Ali AM, Moore C, Brown A, Munoz J, et al. Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes. Investigative Opthalmology & Visual Science. 2023;64(7):35. doi:10.1167/iovs.64.7.35

BibTeX
@article{TrejoCorona2023,
  author = {Trejo Corona, Stephanie and Villanueva Boone, Cecilia and Ali, Amna M and Moore, Chelsey and Brown, Alexandra and Munoz, Jose and Aaberg, Thomas and Schefler, Amy C and ARRT Study Group, ARRT Study Group},
  title = {Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2023},
  volume = {64},
  number = {7},
  pages = {35},
  doi = {10.1167/iovs.64.7.35}
}
Kostenlos starten →